Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Emil HagströmPhillippe Gabriel StegMichael SzarekDeepak L BhattVera A BittnerTabassome SimonRafael DiazShaun G GoodmanRobert A HarringtonJohan Wouter JukemaEvangelos N LiberopoulosNikolaus MarxJennifer McGinnissGaren ManvelianRobert PordyMichel ScemamaHarvey D WhiteAndreas M ZeiherGregory G Schwartznull nullPublished in: Circulation (2022)
gov; Unique identifier: NCT01663402.